First presented at the OPSO Annual CME Conference September 28th in Portland. OPSO is pleased to offer this full day program providing an intensive update in diabetes from a variety of perspectives. Join us for this 5.75 credit program exploring Prediabetes; Diabetes medications and improving patient adherence; Insulin utilation for the treatment of T2DM; Rational goal-setting for the treatment of diabetes in the elderly; Continuous glucose monitoring, and diabetes and pump technology.
Educational Objectives:
– Introduce the audience to the need for DM2 prevention.
– Review the criteria for pre-diabetes.
– Introduce the DPP (Diabetes Prevention Program) and the Oregon Health Authority/OMA Steering Toward Health program that uses the DPP.
– Encourage providers to refer patient who qualify to the DPP.
– Understand evidence-based recommendations for non-insulin therapies for optimal diabetes management
– Define 3 types of non-adherence and the difference between intentional and unintentional non-adherence
– List at least one solution for overcoming the most common barriers to diabetes medications
– Identify the challenges and barriers to diabetes care in the elderly
– Analyze and contrast the ADA-EASD and AACE algorithms for diabetes management, with focus on algorithms’ approach to the elderly where cited in these guidelines
– Interpret recent cardiovascular safety studies for diabetes agents
– Define goals and A1c targets for the elderly population
– Discuss the how and when in starting basal insulin in T2DM
– Explore ways to optimize insulin type and dose
– Use a case based approach to demonstrate best practices in insulin use in type 2 diabetes
Program Outline
Pre-Diabetes Classification and Intervention |
Kevin Miller, DO |
Diabetes Medication and Improving Adherence |
Teresa Martin CDE |
Insulin Utilization for the Treatment of T2DM |
Jay Shubrook, DO |
Rational Goal-Setting and Management of Diabetes in the Elderly |
Michael Shannon, MD |
Continuous Glucose Monitoring |
Eden Miller, DO |
Diabetes and Pump Technology |
Eden Miller, DO |
Drs. Eden Miller, Shannon and Shubrook disclose that they financial affiliation with one or more of the following companies: Abbott, Eli Lilly, Boehringer Engelheim, Novo-Nordisk, Pendulum Pharmaceuticals, Sanofi, MannKind, Bayer, and Intarcia.
The Osteopathic Physicians and Surgeons of Oregon is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians and designates this program for a maximum of 5.75 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.
Grievance Policy:
All grievances may be directed to OPSO Executive Director at [email protected]. All grievances will receive an initial response within 30 days of receipt. If the participant does not receive a satisfactory response, they can submit a complaint to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.